Sri Lanka Exports See Growth in 2025 Amid Tariffs
Apparel exports grew in 2025 despite a year-over-year dip in November, according to the latest figures recently published by Global Data. Continue reading →
Ellucian Officially Acquires Anthology's SIS and ERP Business
The strategic restructuring announced by Anthology in October is playing out as planned, with Ellucian completing its acquisition of Anthology’s Student Information Systems and Enterprise Resource Planning business on Dec. 31. Continue reading →
Asia-Europe ocean carriers add capacity as trade enters peak shipping period
Few blank sailings have been announced for January, and none this week, as shippers in Asia get their cargo on the water ahead of China’s Lunar New Year factory shutdown. Continue reading →
Energy-related transport, metals and mining to lift project cargo sector in 2026
Power generation cargoes gave the heavy-lift sector a welcome boost in 2025, and it’s a cargo stream that will not dry up anytime soon. Continue reading →
Soft volumes to keep West Coast ports congestion-free in early 2026
With inflation increasing, consumer confidence declining and unemployment on the rise, US imports from Asia are not expected to see the typical pre-Lunar New Year surge in January and February. Continue reading →
Several counties drop out of challenge to $340 million Conowingo Dam settlement
Cecil County continues its appeal against Maryland’s Conowingo Dam recertification, while other Eastern Shore counties have withdrawn, fearing delays. Continue reading →
Feds demand compromise on Colorado River while states flounder despite water shortage
Without a strong winter snow season, it’s possible Lake Powell’s levels could drop low enough to cease hydropower production by next October. Continue reading →
Can new hydro development help Tajikistan’s VMKB province meet rising demand?
The Hydropower Sustainability Alliance presented the Power System Plan 2025-2050 for VMKB province in Tajikistan at a ministerial meeting. Continue reading →
Novo Nordisk launches first GLP-1 pill for obesity, but Lilly may dominate the oral market eventually
GLP-1 drugs have become the hottest drug class in a generation, driven by an obesity epidemic affecting 40% of American adults and linked to diabetes, heart disease and a growing list of other conditions. But there’s a catch: up to two-thirds of adults report some level of needle fear. A...